TISSIMA Trademark

Trademark Overview

On Friday, March 6, 2015, a trademark application was filed for TISSIMA with the United States Patent and Trademark Office. The USPTO has given the TISSIMA trademark a serial number of 86555602. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 20, 2023. This trademark is owned by Glaxo Group Limited. The TISSIMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
tissima

General Information

Serial Number86555602
Word MarkTISSIMA
Filing DateFriday, March 6, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 20, 2023
Registration Number5173964
Registration DateTuesday, April 4, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, October 20, 2023CANCELLED SEC. 8 (6-YR)
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 4, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 4, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, February 28, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, February 23, 2017NOTICE OF ALLOWANCE CANCELLED
Monday, February 27, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 23, 2017TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 13, 2016SOU EXTENSION 2 GRANTED
Wednesday, August 3, 2016SOU EXTENSION 2 FILED
Wednesday, August 3, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, March 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 29, 2016SOU EXTENSION 1 GRANTED
Wednesday, February 24, 2016SOU EXTENSION 1 FILED
Monday, March 28, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 24, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, August 25, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 27, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 20, 2015ASSIGNED TO LIE
Tuesday, April 28, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 28, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, April 28, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 28, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, April 28, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, April 24, 2015ASSIGNED TO EXAMINER
Wednesday, March 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 10, 2015NEW APPLICATION ENTERED

Related Keywords

tissima pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological